Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-04-08

AUTHORS

Marcell P. Szabo, Michiyo Iba, Avindra Nath, Eliezer Masliah, Changyoun Kim

ABSTRACT

The coronavirus (COVID-19) pandemic, caused by severe acute respiratory system coronavirus 2 (SARS-CoV-2), has created significant challenges for scientists seeking to understand the pathogenic mechanisms of SARS-CoV-2 infection and to identify the best therapies for infected patients. Although ACE2 is a known receptor for the virus and has been shown to mediate viral entry into the lungs, accumulating reports highlight the presence of neurological symptoms resulting from infection. As ACE2 expression is low in the central nervous system (CNS), these neurological symptoms are unlikely to be caused by ACE2-virus binding. In this review, we will discuss a proposed interaction between SARS-CoV-2 and Toll-like receptor 2 (TLR2) in the CNS. TLR2 is an innate immune receptor that recognizes exogenous microbial components but has also been shown to interact with multiple viral components, including the envelope (E) protein of SARS-CoV-2. In addition, TLR2 plays an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Based on these observations, we hypothesize that TLR2 may play a critical role in the response to SARS-CoV-2 infiltration in the CNS, thereby resulting in the induction or acceleration of AD and PD pathologies in patients. More... »

PAGES

447-454

References to SciGraph publications

  • 2014-07-04. Innate immune responses regulate morphogenesis and degeneration: roles of Toll-like receptors and Sarm1 in neurons in NEUROSCIENCE BULLETIN
  • 2021-02-16. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells in EXPERIMENTAL & MOLECULAR MEDICINE
  • 2021-06-09. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment in ALZHEIMER'S RESEARCH & THERAPY
  • 2020-09-02. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques in NATURE COMMUNICATIONS
  • 2013-03-05. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia in NATURE COMMUNICATIONS
  • 2019-03-20. ApoE4: an emerging therapeutic target for Alzheimer’s disease in BMC MEDICINE
  • 2021-05-07. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines in NATURE IMMUNOLOGY
  • 2012-05-03. TLR9 −1237 T/C and TLR2 −194 to −174 del polymorphisms and the risk of Parkinson’s disease in the Greek population: a pilot study in NEUROLOGICAL SCIENCES
  • 2021-12-28. Detection of SARS-CoV-2-RNA in post-mortem samples of human eyes in GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
  • 2018-07-10. Prevalence of Parkinson’s disease across North America in NPJ PARKINSON'S DISEASE
  • 2020-07-13. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 in CRITICAL CARE
  • 2016-11-25. Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology in ALZHEIMER'S RESEARCH & THERAPY
  • 2016-11-25. Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology in ACTA NEUROPATHOLOGICA
  • 2020-11-30. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 in NATURE NEUROSCIENCE
  • 2014-08-07. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients in ACTA NEUROPATHOLOGICA COMMUNICATIONS
  • 2018-08-09. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation in MOLECULAR NEURODEGENERATION
  • 2020-06-04. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease in ALZHEIMER'S RESEARCH & THERAPY
  • 2020-12-16. The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice in NATURE NEUROSCIENCE
  • 2020-02-14. Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer’s disease mice in JOURNAL OF NEUROINFLAMMATION
  • 2021-03-25. Nervous System Involvement in COVID-19: a Review of the Current Knowledge in MOLECULAR NEUROBIOLOGY
  • 2020-11-30. Toll-like receptor 2 downregulation and cytokine dysregulation predict mortality in patients with Staphylococcus aureus bacteremia in BMC INFECTIOUS DISEASES
  • 2015-11-09. Genetic Factors Affecting Late-Onset Alzheimer’s Disease Susceptibility in NEUROMOLECULAR MEDICINE
  • 2017-03-23. Parkinson disease in NATURE REVIEWS DISEASE PRIMERS
  • 2011-10-11. Toll-like receptor 2 -196 to -174 del polymorphism influences the susceptibility of Han Chinese people to Alzheimer's disease in JOURNAL OF NEUROINFLAMMATION
  • 2021-07-14. SARS-CoV-2: is there neuroinvasion? in FLUIDS AND BARRIERS OF THE CNS
  • 2021-01-23. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) in JOURNAL OF NEUROLOGY
  • 2020-07-21. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? in JOURNAL OF NEUROLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s12276-022-00755-7

    DOI

    http://dx.doi.org/10.1038/s12276-022-00755-7

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1146953984

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/35396576


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Chemical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0304", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medicinal and Biomolecular Chemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Alzheimer Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Angiotensin-Converting Enzyme 2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "COVID-19", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Central Nervous System", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neurodegenerative Diseases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Parkinson Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "SARS-CoV-2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Toll-Like Receptor 2", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA", 
              "id": "http://www.grid.ac/institutes/grid.94365.3d", 
              "name": [
                "Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Szabo", 
            "givenName": "Marcell P.", 
            "id": "sg:person.015000217243.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015000217243.95"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA", 
              "id": "http://www.grid.ac/institutes/grid.94365.3d", 
              "name": [
                "Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Iba", 
            "givenName": "Michiyo", 
            "id": "sg:person.013414154760.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013414154760.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 20892, Bethesda, MD, USA", 
              "id": "http://www.grid.ac/institutes/grid.416870.c", 
              "name": [
                "Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 20892, Bethesda, MD, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nath", 
            "givenName": "Avindra", 
            "id": "sg:person.011644322237.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011644322237.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Neuroscience, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA", 
              "id": "http://www.grid.ac/institutes/grid.94365.3d", 
              "name": [
                "Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA", 
                "Division of Neuroscience, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Masliah", 
            "givenName": "Eliezer", 
            "id": "sg:person.011712740677.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011712740677.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA", 
              "id": "http://www.grid.ac/institutes/grid.94365.3d", 
              "name": [
                "Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kim", 
            "givenName": "Changyoun", 
            "id": "sg:person.01132525732.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132525732.95"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrdp.2017.13", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084129654", 
              "https://doi.org/10.1038/nrdp.2017.13"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12916-019-1299-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1112874626", 
              "https://doi.org/10.1186/s12916-019-1299-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13195-016-0217-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010148235", 
              "https://doi.org/10.1186/s13195-016-0217-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12974-020-01738-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1124885190", 
              "https://doi.org/10.1186/s12974-020-01738-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41590-021-00937-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1137804412", 
              "https://doi.org/10.1038/s41590-021-00937-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13195-020-00640-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1128224657", 
              "https://doi.org/10.1186/s13195-020-00640-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s12276-021-00562-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1135372925", 
              "https://doi.org/10.1038/s12276-021-00562-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10072-012-1106-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001439459", 
              "https://doi.org/10.1007/s10072-012-1106-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00415-021-10406-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1134828583", 
              "https://doi.org/10.1007/s00415-021-10406-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13195-021-00850-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1138738947", 
              "https://doi.org/10.1186/s13195-021-00850-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12879-020-05641-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1132949066", 
              "https://doi.org/10.1186/s12879-020-05641-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12264-014-1445-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050549257", 
              "https://doi.org/10.1007/s12264-014-1445-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13024-018-0276-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106081807", 
              "https://doi.org/10.1186/s13024-018-0276-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncomms2534", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003907929", 
              "https://doi.org/10.1038/ncomms2534"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12035-021-02347-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1136661005", 
              "https://doi.org/10.1007/s12035-021-02347-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12017-015-8376-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024485115", 
              "https://doi.org/10.1007/s12017-015-8376-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41467-020-18149-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1130502743", 
              "https://doi.org/10.1038/s41467-020-18149-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41593-020-00758-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1132983513", 
              "https://doi.org/10.1038/s41593-020-00758-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00417-021-05529-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1144228599", 
              "https://doi.org/10.1007/s00417-021-05529-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12987-021-00267-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1139683952", 
              "https://doi.org/10.1186/s12987-021-00267-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41531-018-0058-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105107309", 
              "https://doi.org/10.1038/s41531-018-0058-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41593-020-00771-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1133536467", 
              "https://doi.org/10.1038/s41593-020-00771-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1742-2094-8-136", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003030272", 
              "https://doi.org/10.1186/1742-2094-8-136"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s40478-014-0090-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041718977", 
              "https://doi.org/10.1186/s40478-014-0090-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13054-020-03120-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1129306791", 
              "https://doi.org/10.1186/s13054-020-03120-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00401-016-1648-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026785744", 
              "https://doi.org/10.1007/s00401-016-1648-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00415-020-10070-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1129492422", 
              "https://doi.org/10.1007/s00415-020-10070-8"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2022-04-08", 
        "datePublishedReg": "2022-04-08", 
        "description": "The coronavirus (COVID-19) pandemic, caused by severe acute respiratory system coronavirus 2 (SARS-CoV-2), has created significant challenges for scientists seeking to understand the pathogenic mechanisms of SARS-CoV-2 infection and to identify the best therapies for infected patients. Although ACE2 is a known receptor for the virus and has been shown to mediate viral entry into the lungs, accumulating reports highlight the presence of neurological symptoms resulting from infection. As ACE2 expression is low in the central nervous system (CNS), these neurological symptoms are unlikely to be caused by ACE2-virus binding. In this review, we will discuss a proposed interaction between SARS-CoV-2 and Toll-like receptor 2 (TLR2) in the CNS. TLR2 is an innate immune receptor that recognizes exogenous microbial components but has also been shown to interact with multiple viral components, including the envelope (E) protein of SARS-CoV-2. In addition, TLR2 plays an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD). Based on these observations, we hypothesize that TLR2 may play a critical role in the response to SARS-CoV-2 infiltration in the CNS, thereby resulting in the induction or acceleration of AD and PD pathologies in patients.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s12276-022-00755-7", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1085098", 
            "issn": [
              "1226-3613", 
              "2092-6413"
            ], 
            "name": "Experimental & Molecular Medicine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "54"
          }
        ], 
        "keywords": [
          "Toll-like receptor 2", 
          "central nervous system", 
          "SARS-CoV-2", 
          "Alzheimer's disease", 
          "neurological symptoms", 
          "Parkinson's disease", 
          "SARS-CoV-2 infiltration", 
          "SARS-CoV-2 infection", 
          "innate immune receptors", 
          "ACE2 expression", 
          "coronavirus 2", 
          "infected patients", 
          "best therapy", 
          "PD pathology", 
          "receptor 2", 
          "pathogenic mechanisms", 
          "nervous system", 
          "neurodegenerative disorders", 
          "viral entry", 
          "neurodegenerative diseases", 
          "disease", 
          "immune receptors", 
          "multiple viral components", 
          "receptors", 
          "viral components", 
          "patients", 
          "envelope protein", 
          "symptoms", 
          "infection", 
          "potential receptors", 
          "microbial components", 
          "critical role", 
          "lung", 
          "pathogenesis", 
          "therapy", 
          "ACE2", 
          "pathology", 
          "important role", 
          "disorders", 
          "infiltration", 
          "virus", 
          "coronavirus pandemic", 
          "induction", 
          "role", 
          "report", 
          "pandemic", 
          "review", 
          "expression", 
          "response", 
          "protein", 
          "significant challenge", 
          "binding", 
          "entry", 
          "presence", 
          "mechanism", 
          "addition", 
          "components", 
          "challenges", 
          "observations", 
          "interaction", 
          "system", 
          "acceleration", 
          "scientists"
        ], 
        "name": "Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS", 
        "pagination": "447-454", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1146953984"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s12276-022-00755-7"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "35396576"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s12276-022-00755-7", 
          "https://app.dimensions.ai/details/publication/pub.1146953984"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-06-01T22:24", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_932.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s12276-022-00755-7"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s12276-022-00755-7'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s12276-022-00755-7'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s12276-022-00755-7'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s12276-022-00755-7'


     

    This table displays all metadata directly associated to this object as RDF triples.

    302 TRIPLES      22 PREDICATES      125 URIs      90 LITERALS      16 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s12276-022-00755-7 schema:about N3f080b6408a94bd882212858966032a7
    2 N5452d2f8a9f543dbbbd603d08a805684
    3 N73283eacc008486fa7b10ac4f26880dd
    4 N7503d89eb70449ab86d183ed888ac386
    5 Na269e55f675043aeabc0b51c2191fa50
    6 Na7e79898f16543eaa0ab83c6b34a38eb
    7 Nc2f2577f1bf343e680fffa088d784f1b
    8 Nf8eba372a9664558b78fe552ca6bc457
    9 Nf9ca08b8ab5145f7b862b4bd1bedf0b6
    10 anzsrc-for:03
    11 anzsrc-for:0304
    12 schema:author N0367c229bd234e8185732a096c0e05a0
    13 schema:citation sg:pub.10.1007/s00401-016-1648-8
    14 sg:pub.10.1007/s00415-020-10070-8
    15 sg:pub.10.1007/s00415-021-10406-y
    16 sg:pub.10.1007/s00417-021-05529-x
    17 sg:pub.10.1007/s10072-012-1106-x
    18 sg:pub.10.1007/s12017-015-8376-4
    19 sg:pub.10.1007/s12035-021-02347-4
    20 sg:pub.10.1007/s12264-014-1445-5
    21 sg:pub.10.1038/ncomms2534
    22 sg:pub.10.1038/nrdp.2017.13
    23 sg:pub.10.1038/s12276-021-00562-6
    24 sg:pub.10.1038/s41467-020-18149-6
    25 sg:pub.10.1038/s41531-018-0058-0
    26 sg:pub.10.1038/s41590-021-00937-x
    27 sg:pub.10.1038/s41593-020-00758-5
    28 sg:pub.10.1038/s41593-020-00771-8
    29 sg:pub.10.1186/1742-2094-8-136
    30 sg:pub.10.1186/s12879-020-05641-z
    31 sg:pub.10.1186/s12916-019-1299-4
    32 sg:pub.10.1186/s12974-020-01738-z
    33 sg:pub.10.1186/s12987-021-00267-y
    34 sg:pub.10.1186/s13024-018-0276-2
    35 sg:pub.10.1186/s13054-020-03120-0
    36 sg:pub.10.1186/s13195-016-0217-7
    37 sg:pub.10.1186/s13195-020-00640-3
    38 sg:pub.10.1186/s13195-021-00850-3
    39 sg:pub.10.1186/s40478-014-0090-1
    40 schema:datePublished 2022-04-08
    41 schema:datePublishedReg 2022-04-08
    42 schema:description The coronavirus (COVID-19) pandemic, caused by severe acute respiratory system coronavirus 2 (SARS-CoV-2), has created significant challenges for scientists seeking to understand the pathogenic mechanisms of SARS-CoV-2 infection and to identify the best therapies for infected patients. Although ACE2 is a known receptor for the virus and has been shown to mediate viral entry into the lungs, accumulating reports highlight the presence of neurological symptoms resulting from infection. As ACE2 expression is low in the central nervous system (CNS), these neurological symptoms are unlikely to be caused by ACE2-virus binding. In this review, we will discuss a proposed interaction between SARS-CoV-2 and Toll-like receptor 2 (TLR2) in the CNS. TLR2 is an innate immune receptor that recognizes exogenous microbial components but has also been shown to interact with multiple viral components, including the envelope (E) protein of SARS-CoV-2. In addition, TLR2 plays an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Based on these observations, we hypothesize that TLR2 may play a critical role in the response to SARS-CoV-2 infiltration in the CNS, thereby resulting in the induction or acceleration of AD and PD pathologies in patients.
    43 schema:genre article
    44 schema:inLanguage en
    45 schema:isAccessibleForFree true
    46 schema:isPartOf N767b2e02031c4152925cc9c2c4c938dc
    47 N8a91ef0226124f22917d249d86cb7457
    48 sg:journal.1085098
    49 schema:keywords ACE2
    50 ACE2 expression
    51 Alzheimer's disease
    52 PD pathology
    53 Parkinson's disease
    54 SARS-CoV-2
    55 SARS-CoV-2 infection
    56 SARS-CoV-2 infiltration
    57 Toll-like receptor 2
    58 acceleration
    59 addition
    60 best therapy
    61 binding
    62 central nervous system
    63 challenges
    64 components
    65 coronavirus 2
    66 coronavirus pandemic
    67 critical role
    68 disease
    69 disorders
    70 entry
    71 envelope protein
    72 expression
    73 immune receptors
    74 important role
    75 induction
    76 infected patients
    77 infection
    78 infiltration
    79 innate immune receptors
    80 interaction
    81 lung
    82 mechanism
    83 microbial components
    84 multiple viral components
    85 nervous system
    86 neurodegenerative diseases
    87 neurodegenerative disorders
    88 neurological symptoms
    89 observations
    90 pandemic
    91 pathogenesis
    92 pathogenic mechanisms
    93 pathology
    94 patients
    95 potential receptors
    96 presence
    97 protein
    98 receptor 2
    99 receptors
    100 report
    101 response
    102 review
    103 role
    104 scientists
    105 significant challenge
    106 symptoms
    107 system
    108 therapy
    109 viral components
    110 viral entry
    111 virus
    112 schema:name Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS
    113 schema:pagination 447-454
    114 schema:productId N06f267fb3fd346d6bb6f3a9695944f9f
    115 N0ad30859eef44844b4860c2b6d0028ca
    116 Nee8fe12877c24f548ab561e39f18eb14
    117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1146953984
    118 https://doi.org/10.1038/s12276-022-00755-7
    119 schema:sdDatePublished 2022-06-01T22:24
    120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    121 schema:sdPublisher N95741b0b303b4d39ac2dc7587f15b86d
    122 schema:url https://doi.org/10.1038/s12276-022-00755-7
    123 sgo:license sg:explorer/license/
    124 sgo:sdDataset articles
    125 rdf:type schema:ScholarlyArticle
    126 N0367c229bd234e8185732a096c0e05a0 rdf:first sg:person.015000217243.95
    127 rdf:rest N97a050f8fa6a440e9d983644656f1e2a
    128 N06f267fb3fd346d6bb6f3a9695944f9f schema:name pubmed_id
    129 schema:value 35396576
    130 rdf:type schema:PropertyValue
    131 N0ad30859eef44844b4860c2b6d0028ca schema:name dimensions_id
    132 schema:value pub.1146953984
    133 rdf:type schema:PropertyValue
    134 N28742e2bcf3a4cc8adf318e4c1206e58 rdf:first sg:person.011712740677.92
    135 rdf:rest Nfc9f7e11d50f40b9b5bc36db4d9dd823
    136 N385733143ca74911b270967cb4d75e3f rdf:first sg:person.011644322237.52
    137 rdf:rest N28742e2bcf3a4cc8adf318e4c1206e58
    138 N3f080b6408a94bd882212858966032a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name SARS-CoV-2
    140 rdf:type schema:DefinedTerm
    141 N5452d2f8a9f543dbbbd603d08a805684 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Central Nervous System
    143 rdf:type schema:DefinedTerm
    144 N73283eacc008486fa7b10ac4f26880dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Toll-Like Receptor 2
    146 rdf:type schema:DefinedTerm
    147 N7503d89eb70449ab86d183ed888ac386 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Angiotensin-Converting Enzyme 2
    149 rdf:type schema:DefinedTerm
    150 N767b2e02031c4152925cc9c2c4c938dc schema:volumeNumber 54
    151 rdf:type schema:PublicationVolume
    152 N8a91ef0226124f22917d249d86cb7457 schema:issueNumber 4
    153 rdf:type schema:PublicationIssue
    154 N95741b0b303b4d39ac2dc7587f15b86d schema:name Springer Nature - SN SciGraph project
    155 rdf:type schema:Organization
    156 N97a050f8fa6a440e9d983644656f1e2a rdf:first sg:person.013414154760.49
    157 rdf:rest N385733143ca74911b270967cb4d75e3f
    158 Na269e55f675043aeabc0b51c2191fa50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Alzheimer Disease
    160 rdf:type schema:DefinedTerm
    161 Na7e79898f16543eaa0ab83c6b34a38eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Neurodegenerative Diseases
    163 rdf:type schema:DefinedTerm
    164 Nc2f2577f1bf343e680fffa088d784f1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Parkinson Disease
    166 rdf:type schema:DefinedTerm
    167 Nee8fe12877c24f548ab561e39f18eb14 schema:name doi
    168 schema:value 10.1038/s12276-022-00755-7
    169 rdf:type schema:PropertyValue
    170 Nf8eba372a9664558b78fe552ca6bc457 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name COVID-19
    172 rdf:type schema:DefinedTerm
    173 Nf9ca08b8ab5145f7b862b4bd1bedf0b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Humans
    175 rdf:type schema:DefinedTerm
    176 Nfc9f7e11d50f40b9b5bc36db4d9dd823 rdf:first sg:person.01132525732.95
    177 rdf:rest rdf:nil
    178 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
    179 schema:name Chemical Sciences
    180 rdf:type schema:DefinedTerm
    181 anzsrc-for:0304 schema:inDefinedTermSet anzsrc-for:
    182 schema:name Medicinal and Biomolecular Chemistry
    183 rdf:type schema:DefinedTerm
    184 sg:journal.1085098 schema:issn 1226-3613
    185 2092-6413
    186 schema:name Experimental & Molecular Medicine
    187 schema:publisher Springer Nature
    188 rdf:type schema:Periodical
    189 sg:person.01132525732.95 schema:affiliation grid-institutes:grid.94365.3d
    190 schema:familyName Kim
    191 schema:givenName Changyoun
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132525732.95
    193 rdf:type schema:Person
    194 sg:person.011644322237.52 schema:affiliation grid-institutes:grid.416870.c
    195 schema:familyName Nath
    196 schema:givenName Avindra
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011644322237.52
    198 rdf:type schema:Person
    199 sg:person.011712740677.92 schema:affiliation grid-institutes:grid.94365.3d
    200 schema:familyName Masliah
    201 schema:givenName Eliezer
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011712740677.92
    203 rdf:type schema:Person
    204 sg:person.013414154760.49 schema:affiliation grid-institutes:grid.94365.3d
    205 schema:familyName Iba
    206 schema:givenName Michiyo
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013414154760.49
    208 rdf:type schema:Person
    209 sg:person.015000217243.95 schema:affiliation grid-institutes:grid.94365.3d
    210 schema:familyName Szabo
    211 schema:givenName Marcell P.
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015000217243.95
    213 rdf:type schema:Person
    214 sg:pub.10.1007/s00401-016-1648-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026785744
    215 https://doi.org/10.1007/s00401-016-1648-8
    216 rdf:type schema:CreativeWork
    217 sg:pub.10.1007/s00415-020-10070-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129492422
    218 https://doi.org/10.1007/s00415-020-10070-8
    219 rdf:type schema:CreativeWork
    220 sg:pub.10.1007/s00415-021-10406-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1134828583
    221 https://doi.org/10.1007/s00415-021-10406-y
    222 rdf:type schema:CreativeWork
    223 sg:pub.10.1007/s00417-021-05529-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1144228599
    224 https://doi.org/10.1007/s00417-021-05529-x
    225 rdf:type schema:CreativeWork
    226 sg:pub.10.1007/s10072-012-1106-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001439459
    227 https://doi.org/10.1007/s10072-012-1106-x
    228 rdf:type schema:CreativeWork
    229 sg:pub.10.1007/s12017-015-8376-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024485115
    230 https://doi.org/10.1007/s12017-015-8376-4
    231 rdf:type schema:CreativeWork
    232 sg:pub.10.1007/s12035-021-02347-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1136661005
    233 https://doi.org/10.1007/s12035-021-02347-4
    234 rdf:type schema:CreativeWork
    235 sg:pub.10.1007/s12264-014-1445-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050549257
    236 https://doi.org/10.1007/s12264-014-1445-5
    237 rdf:type schema:CreativeWork
    238 sg:pub.10.1038/ncomms2534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003907929
    239 https://doi.org/10.1038/ncomms2534
    240 rdf:type schema:CreativeWork
    241 sg:pub.10.1038/nrdp.2017.13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084129654
    242 https://doi.org/10.1038/nrdp.2017.13
    243 rdf:type schema:CreativeWork
    244 sg:pub.10.1038/s12276-021-00562-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1135372925
    245 https://doi.org/10.1038/s12276-021-00562-6
    246 rdf:type schema:CreativeWork
    247 sg:pub.10.1038/s41467-020-18149-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130502743
    248 https://doi.org/10.1038/s41467-020-18149-6
    249 rdf:type schema:CreativeWork
    250 sg:pub.10.1038/s41531-018-0058-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105107309
    251 https://doi.org/10.1038/s41531-018-0058-0
    252 rdf:type schema:CreativeWork
    253 sg:pub.10.1038/s41590-021-00937-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1137804412
    254 https://doi.org/10.1038/s41590-021-00937-x
    255 rdf:type schema:CreativeWork
    256 sg:pub.10.1038/s41593-020-00758-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132983513
    257 https://doi.org/10.1038/s41593-020-00758-5
    258 rdf:type schema:CreativeWork
    259 sg:pub.10.1038/s41593-020-00771-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1133536467
    260 https://doi.org/10.1038/s41593-020-00771-8
    261 rdf:type schema:CreativeWork
    262 sg:pub.10.1186/1742-2094-8-136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003030272
    263 https://doi.org/10.1186/1742-2094-8-136
    264 rdf:type schema:CreativeWork
    265 sg:pub.10.1186/s12879-020-05641-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1132949066
    266 https://doi.org/10.1186/s12879-020-05641-z
    267 rdf:type schema:CreativeWork
    268 sg:pub.10.1186/s12916-019-1299-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112874626
    269 https://doi.org/10.1186/s12916-019-1299-4
    270 rdf:type schema:CreativeWork
    271 sg:pub.10.1186/s12974-020-01738-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1124885190
    272 https://doi.org/10.1186/s12974-020-01738-z
    273 rdf:type schema:CreativeWork
    274 sg:pub.10.1186/s12987-021-00267-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1139683952
    275 https://doi.org/10.1186/s12987-021-00267-y
    276 rdf:type schema:CreativeWork
    277 sg:pub.10.1186/s13024-018-0276-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106081807
    278 https://doi.org/10.1186/s13024-018-0276-2
    279 rdf:type schema:CreativeWork
    280 sg:pub.10.1186/s13054-020-03120-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129306791
    281 https://doi.org/10.1186/s13054-020-03120-0
    282 rdf:type schema:CreativeWork
    283 sg:pub.10.1186/s13195-016-0217-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010148235
    284 https://doi.org/10.1186/s13195-016-0217-7
    285 rdf:type schema:CreativeWork
    286 sg:pub.10.1186/s13195-020-00640-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128224657
    287 https://doi.org/10.1186/s13195-020-00640-3
    288 rdf:type schema:CreativeWork
    289 sg:pub.10.1186/s13195-021-00850-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1138738947
    290 https://doi.org/10.1186/s13195-021-00850-3
    291 rdf:type schema:CreativeWork
    292 sg:pub.10.1186/s40478-014-0090-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041718977
    293 https://doi.org/10.1186/s40478-014-0090-1
    294 rdf:type schema:CreativeWork
    295 grid-institutes:grid.416870.c schema:alternateName Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 20892, Bethesda, MD, USA
    296 schema:name Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 20892, Bethesda, MD, USA
    297 rdf:type schema:Organization
    298 grid-institutes:grid.94365.3d schema:alternateName Division of Neuroscience, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA
    299 Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA
    300 schema:name Division of Neuroscience, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA
    301 Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA
    302 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...